These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
192 related articles for article (PubMed ID: 6319107)
1. New and experimental therapeutic roles for naloxone and related opioid antagonists. McNicholas LF; Martin WR Drugs; 1984 Jan; 27(1):81-93. PubMed ID: 6319107 [TBL] [Abstract][Full Text] [Related]
2. Action of naloxone and naltrexone in different types of psychoses. Volavka J Mod Probl Pharmacopsychiatry; 1981; 17():202-12. PubMed ID: 6276726 [No Abstract] [Full Text] [Related]
3. Opiate antagonists in shock and trauma. Holaday JW Am J Emerg Med; 1984 Jan; 2(1):8-12. PubMed ID: 6097276 [TBL] [Abstract][Full Text] [Related]
4. Longer occupancy of opioid receptors by nalmefene compared to naloxone as measured in vivo by a dual-detector system. Kim S; Wagner HN; Villemagne VL; Kao PF; Dannals RF; Ravert HT; Joh T; Dixon RB; Civelek AC J Nucl Med; 1997 Nov; 38(11):1726-31. PubMed ID: 9374341 [TBL] [Abstract][Full Text] [Related]
5. Role of thyrotropin-releasing hormone and opiate receptor antagonists in limiting central nervous system injury. Faden AI Adv Neurol; 1988; 47():531-46. PubMed ID: 2830771 [TBL] [Abstract][Full Text] [Related]
6. Naloxone and naltrexone. Application in COPD. Reents SB; Beck CA Chest; 1988 Jan; 93(1):217-9. PubMed ID: 3121260 [TBL] [Abstract][Full Text] [Related]
11. [Naloxone and naltrexone in the therapy of advanced COPD]. Foresti V; De Filippi G; Casati O; Zubani R; Scolari N Recenti Prog Med; 1991 Apr; 82(4):230-2. PubMed ID: 1857843 [TBL] [Abstract][Full Text] [Related]
12. Treatment of stroke with opiate antagonists--effects of exogenous antagonists and dynorphin 1-13. Baskin DS; Kuroda H; Hosobuchi Y; Lee NM Neuropeptides; 1985 Feb; 5(4-6):307-10. PubMed ID: 2860592 [TBL] [Abstract][Full Text] [Related]
13. Multiple opioid receptors mediate the hypotensive response induced by central 5-HT(3) receptor stimulation. Fregoneze JB; Oliveira EF; Ribeiro VF; Ferreira HS; De Castro E Silva E Neuropeptides; 2011 Jun; 45(3):219-27. PubMed ID: 21514668 [TBL] [Abstract][Full Text] [Related]
14. Opiate antagonist in traumatic shock. McIntosh TK; Faden AI Ann Emerg Med; 1986 Dec; 15(12):1462-5. PubMed ID: 3022620 [TBL] [Abstract][Full Text] [Related]
15. Psychotic spectrum disorders and alcohol abuse: a review of pharmacotherapeutic strategies and a report on the effectiveness of naltrexone and disulfiram. Petrakis IL; Nich C; Ralevski E Schizophr Bull; 2006 Oct; 32(4):644-54. PubMed ID: 16887890 [TBL] [Abstract][Full Text] [Related]
16. [Neurochemical basis of ultra rapid opioid detoxication]. Golovko AI; Leont'eva LV; Golovko SI; Zefirov SIu; Konoplin DA; Romanenko OP Vopr Med Khim; 2002; 48(2):154-73. PubMed ID: 12189623 [TBL] [Abstract][Full Text] [Related]
19. Opioid Use Disorders. Sharma B; Bruner A; Barnett G; Fishman M Child Adolesc Psychiatr Clin N Am; 2016 Jul; 25(3):473-87. PubMed ID: 27338968 [TBL] [Abstract][Full Text] [Related]
20. Opiate antagonists and thyrotropin-releasing hormone. I. Potential role in the treatment of shock. Faden AI JAMA; 1984 Sep; 252(9):1177-80. PubMed ID: 6088820 [No Abstract] [Full Text] [Related] [Next] [New Search]